Management of polycystic ovary syndrome involves addressing current needs and preventing long-term consequences

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.5, 2007-05, pp. : 12-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

As adjuncts to diet, flutamide and metformin provide long-term, complementary benefits in overweight-obese women with polycystic ovary syndrome

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Diagnosis and Management of Polycystic Ovary Syndrome: A Practical Guide

By Stankiewicz Marcin

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 903-912

Adis International

Access to resources Recommend Favorite

Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management

Current Pharmaceutical Design, Vol. 22, Iss. 36, 2016-10 ,pp. : 5603-5613

Bentham Science Publishers

Access to resources Recommend Favorite

Polycystic Ovary Syndrome in Adolescents: Current and Future Treatment Options

By Mastorakos George Lambrinoudaki Irene Creatsas George

Pediatric Drugs, Vol. 8, Iss. 5, 2006-01 ,pp. : 311-318

Adis International

Access to resources Recommend Favorite

Polycystic ovary syndrome

By Franks Stephen

Clinical Medicine, Vol. 32, Iss. 2, 1998-03 ,pp. : 111-113

Royal College Of Physicians

Access to resources Recommend Favorite